344 related articles for article (PubMed ID: 15193409)
1. European union regulatory developments for new vaccine adjuvants and delivery systems.
Sesardic D; Dobbelaer R
Vaccine; 2004 Jun; 22(19):2452-6. PubMed ID: 15193409
[TBL] [Abstract][Full Text] [Related]
2. New adjuvants: EU regulatory developments.
Sesardic D; Rijpkema S; Patel BP
Expert Rev Vaccines; 2007 Oct; 6(5):849-61. PubMed ID: 17931163
[TBL] [Abstract][Full Text] [Related]
3. Current adjuvants and new perspectives in vaccine formulation.
Montomoli E; Piccirella S; Khadang B; Mennitto E; Camerini R; De Rosa A
Expert Rev Vaccines; 2011 Jul; 10(7):1053-61. PubMed ID: 21806399
[TBL] [Abstract][Full Text] [Related]
4. The path to a successful vaccine adjuvant--'the long and winding road'.
O'Hagan DT; De Gregorio E
Drug Discov Today; 2009 Jun; 14(11-12):541-51. PubMed ID: 19508916
[TBL] [Abstract][Full Text] [Related]
5. Adjuvants and delivery issues related to immunization: a survey of the recent patent literature.
Mrsny RJ
J Drug Target; 1998; 6(4):243-9. PubMed ID: 9894692
[TBL] [Abstract][Full Text] [Related]
6. Adjuvants and delivery systems for viral vaccines--mechanisms and potential.
Jennings R; Simms JR; Heath AW
Dev Biol Stand; 1998; 92():19-28. PubMed ID: 9554256
[TBL] [Abstract][Full Text] [Related]
7. Non-clinical safety evaluation of novel vaccines and adjuvants: new products, new strategies.
Brennan FR; Dougan G
Vaccine; 2005 May; 23(24):3210-22. PubMed ID: 15837222
[TBL] [Abstract][Full Text] [Related]
8. MF59-adjuvanted vaccines: increased immunogenicity with an optimal safety profile.
Podda A; Del Giudice G
Expert Rev Vaccines; 2003 Apr; 2(2):197-203. PubMed ID: 12899571
[TBL] [Abstract][Full Text] [Related]
9. Influenza vaccine with squalene adjuvant: new preparation. No better than available products.
Prescrire Int; 2004 Dec; 13(74):206-8. PubMed ID: 15599987
[TBL] [Abstract][Full Text] [Related]
10. Antibody and T-cell responses to a virosomal adjuvanted H9N2 avian influenza vaccine: impact of distinct additional adjuvants.
Radosević K; Rodriguez A; Mintardjo R; Tax D; Bengtsson KL; Thompson C; Zambon M; Weverling GJ; Uytdehaag F; Goudsmit J
Vaccine; 2008 Jul; 26(29-30):3640-6. PubMed ID: 18514980
[TBL] [Abstract][Full Text] [Related]
11. Fully mobilizing host defense: building better vaccines.
Raychaudhuri S; Rock KL
Nat Biotechnol; 1998 Nov; 16(11):1025-31. PubMed ID: 9831030
[TBL] [Abstract][Full Text] [Related]
12. Survey of human-use adjuvants.
Kenney RT; Edelman R
Expert Rev Vaccines; 2003 Apr; 2(2):167-88. PubMed ID: 12899569
[TBL] [Abstract][Full Text] [Related]
13. Mucosal delivery of vaccine antigens and its advantages in pediatrics.
De Magistris MT
Adv Drug Deliv Rev; 2006 Apr; 58(1):52-67. PubMed ID: 16516335
[TBL] [Abstract][Full Text] [Related]
14. New horizons in adjuvants for vaccine development.
Reed SG; Bertholet S; Coler RN; Friede M
Trends Immunol; 2009 Jan; 30(1):23-32. PubMed ID: 19059004
[TBL] [Abstract][Full Text] [Related]
15. Vaccine adjuvant systems: enhancing the efficacy of sub-unit protein antigens.
Perrie Y; Mohammed AR; Kirby DJ; McNeil SE; Bramwell VW
Int J Pharm; 2008 Dec; 364(2):272-80. PubMed ID: 18555624
[TBL] [Abstract][Full Text] [Related]
16. Status and future prospects of lipid-based particulate delivery systems as vaccine adjuvants and their combination with immunostimulators.
Nordly P; Madsen HB; Nielsen HM; Foged C
Expert Opin Drug Deliv; 2009 Jul; 6(7):657-72. PubMed ID: 19538037
[TBL] [Abstract][Full Text] [Related]
17. Immunity in response to particulate antigen-delivery systems.
Storni T; Kündig TM; Senti G; Johansen P
Adv Drug Deliv Rev; 2005 Jan; 57(3):333-55. PubMed ID: 15560945
[TBL] [Abstract][Full Text] [Related]
18. Cationic liposomes as vaccine adjuvants.
Christensen D; Korsholm KS; Andersen P; Agger EM
Expert Rev Vaccines; 2011 Apr; 10(4):513-21. PubMed ID: 21506648
[TBL] [Abstract][Full Text] [Related]
19. Biophysical validation of Epaxal Berna, a hepatitis A vaccine adjuvanted with immunopotentiating reconstituted influenza virosomes (IRIV).
Glück R; Wälti E
Dev Biol (Basel); 2000; 103():189-97. PubMed ID: 11214236
[TBL] [Abstract][Full Text] [Related]
20. [Adjuvants--essential components of new generation vaccines].
Dzierzbicka K; Kołodziejczyk AM
Postepy Biochem; 2006; 52(2):204-11. PubMed ID: 17078510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
